These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
496 related items for PubMed ID: 12689334
1. Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. De Cristofaro R, De Filippis V. Biochem J; 2003 Jul 15; 373(Pt 2):593-601. PubMed ID: 12689334 [Abstract] [Full Text] [Related]
2. The Asp(272)-Glu(282) region of platelet glycoprotein Ibalpha interacts with the heparin-binding site of alpha-thrombin and protects the enzyme from the heparin-catalyzed inhibition by antithrombin III. De Cristofaro R, De Candia E, Rutella S, Weitz JI. J Biol Chem; 2000 Feb 11; 275(6):3887-95. PubMed ID: 10660541 [Abstract] [Full Text] [Related]
3. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity. Takeyama M, Nogami K, Matsumoto T, Soeda T, Suzuki T, Hattori K, Shima M. Thromb Haemost; 2010 Jan 11; 103(1):94-102. PubMed ID: 20062922 [Abstract] [Full Text] [Related]
4. Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372. Nogami K, Saenko EL, Takeyama M, Giddings JC, Yoshioka A, Shima M. Br J Haematol; 2008 Feb 11; 140(4):433-43. PubMed ID: 18081893 [Abstract] [Full Text] [Related]
5. Thrombin interaction with platelet GpIB: role of the heparin binding domain. De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M, Landolfi R. Thromb Haemost; 1997 Apr 11; 77(4):735-40. PubMed ID: 9134652 [Abstract] [Full Text] [Related]
6. Characteristics of the interaction between thrombin exosite 1 and the sequence 269-287 [correction of 269-297] of platelet glycoprotein Ibalpha. Bouton MC, Thurieau C, Guillin MC, Jandrot-Perrus M. Thromb Haemost; 1998 Aug 11; 80(2):310-5. PubMed ID: 9716158 [Abstract] [Full Text] [Related]
7. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y, Zhang W, Yan R, Liao Y, Zhao L, Ruan C, Du X, Dai K. Circ Res; 2009 Dec 04; 105(12):1177-85. PubMed ID: 19875727 [Abstract] [Full Text] [Related]
8. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA, Smith TM, Cunningham K, Jacob J, DeSilva T, Lin L, Shaw GD, Kriz R, Kelleher KS. Biochemistry; 2008 Apr 22; 47(16):4674-82. PubMed ID: 18363340 [Abstract] [Full Text] [Related]
10. Crystal structure of the GpIbalpha-thrombin complex essential for platelet aggregation. Dumas JJ, Kumar R, Seehra J, Somers WS, Mosyak L. Science; 2003 Jul 11; 301(5630):222-6. PubMed ID: 12855811 [Abstract] [Full Text] [Related]
11. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. De Cristofaro R, De Candia E, Landolfi R, Rutella S, Hall SW. Biochemistry; 2001 Nov 06; 40(44):13268-73. PubMed ID: 11683636 [Abstract] [Full Text] [Related]
12. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism. Ulrichts H, Vanhoorelbeke K, Cauwenberghs S, Vauterin S, Kroll H, Santoso S, Deckmyn H. Arterioscler Thromb Vasc Biol; 2003 Jul 01; 23(7):1302-7. PubMed ID: 12775575 [Abstract] [Full Text] [Related]
13. Expression of the amino-terminal domain of platelet glycoprotein Ib alpha: exploitation of a calmodulin tag for determination of its functional activity. Li CQ, Ye P, Cao Zf, Wang H, Lu L, Nicastro P, Wood E, Robert JJ, Ouwehand WH, Hill F, López JA, Wardell MR. Protein Expr Purif; 2001 Jul 01; 22(2):200-10. PubMed ID: 11437595 [Abstract] [Full Text] [Related]
14. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Xu G, Ulrichts H, Vauterin S, De Meyer SF, Deckmyn H, Teng M, Niu L. Toxicon; 2005 Apr 01; 45(5):561-70. PubMed ID: 15777951 [Abstract] [Full Text] [Related]
15. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism. Nogami K, Shima M, Nishiya K, Sakurai Y, Tanaka I, Giddings JC, Saenko EL, Yoshioka A. Thromb Haemost; 2002 Mar 01; 87(3):459-65. PubMed ID: 11916079 [Abstract] [Full Text] [Related]
16. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. De Candia E, Hall SW, Rutella S, Landolfi R, Andrews RK, De Cristofaro R. J Biol Chem; 2001 Feb 16; 276(7):4692-8. PubMed ID: 11084032 [Abstract] [Full Text] [Related]
17. Role of factor VIII C2 domain in factor VIII binding to factor Xa. Nogami K, Shima M, Hosokawa K, Suzuki T, Koide T, Saenko EL, Scandella D, Shibata M, Kamisue S, Tanaka I, Yoshioka A. J Biol Chem; 1999 Oct 22; 274(43):31000-7. PubMed ID: 10521497 [Abstract] [Full Text] [Related]
18. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Baglia FA, Walsh PN. Biochemistry; 1998 Feb 24; 37(8):2271-81. PubMed ID: 9485373 [Abstract] [Full Text] [Related]
19. Modulation of alpha-thrombin function by distinct interactions with platelet glycoprotein Ibalpha. Celikel R, McClintock RA, Roberts JR, Mendolicchio GL, Ware J, Varughese KI, Ruggeri ZM. Science; 2003 Jul 11; 301(5630):218-21. PubMed ID: 12855810 [Abstract] [Full Text] [Related]
20. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X. Khrenov AV, Ananyeva NM, Saenko EL. Blood Coagul Fibrinolysis; 2006 Jul 11; 17(5):379-88. PubMed ID: 16788314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]